Pharmaids Pharmaceuticals Ltd announced an open offer to acquire up to 9,169,632 equity shares at ₹62.15 each, totaling approximately ₹56.99 crores, with recommendations from the Committee of Independent Directors published in newspapers on July 30, 2025.